RSV fusion inhibitor GS-5806
Term · Oncology and biomedicine · MLC-T-ONC-016595
An orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. Upon oral administration of GS-5806, this agent specifically binds to F protein on the viral surface, which inhibits RSV F protein-mediated fusion with the host cell membrane and prevents viral entry. This blocks RSV replication, reduces viral load, and decreases the severity of the disease. RSV F protein, a viral surface glycoprotein, plays a key role in RSV fusion with and entry into target cells.
| Identifier | MLC-T-ONC-016595 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | GS-5806; respiratory syncytial virus fusion inhibitor GS-5806 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016595",
"term": "RSV fusion inhibitor GS-5806",
"field": "Oncology and biomedicine",
"definition": "An orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. Upon oral administration of GS-5806, this agent specifically binds to F protein on the viral surface, which inhibits RSV F protein-mediated fusion with the host cell membrane and prevents viral entry. This blocks RSV replication, reduces viral load, and decreases the severity of the disease. RSV F protein, a viral surface glycoprotein, plays a key role in RSV fusion with and entry into target cells.",
"synonyms": [
"GS-5806",
"respiratory syncytial virus fusion inhibitor GS-5806"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rsv-fusion-inhibitor-gs-5806/"
}
Record 14,591 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.